menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
ReachMD Faculty

Public Profile

James R. Gavin, III, MD, PhD
James R. Gavin, III, MD, PhD
  • Healing Our Village, Inc.

James R. Gavin III, MD, PhD is clinical professor of medicine at Emory University School of
Medicine and at the Indiana University School of Medicine. He serves as CEO and Chief Medical Officer of Healing Our Village, Inc. He also served as senior scientific officer at the Howard Hughes Medical Institute. Dr. Gavin was a professor and chief of the Diabetes Section at the University of Oklahoma. He belongs to a number of organizations, including the Institute of Medicine, the American Diabetes Association (ADA), the American Society of Clinical Investigation, the American Association of Physicians, and the Atlanta Rotary Club. He is a past president of the ADA, and Chairman Emeritus of the National Diabetes Education Program. He is on the board of trustees for Emory University and Livingstone College. He serves as a Director on the Board of Baxter International, Inc. He is national program director of the Harold Amos Medical Faculty Development Program of the Robert Wood Johnson Foundation, and Chairman of the Board for The Partnership for a Healthier America. He is Chairman of the Data Safety Monitoring Board for the VADT. He has published over 225 articles and two books. He received the Emory Medal for Distinguished Achievement, the Banting Medal for Distinguished Service, and the Distinguished Alumni Award from Duke University School of Medicine. He was named a Living Legend in Diabetes by AADE in 2009, and received the Public Policy Leadership Award from the ADA in 2010. He was named an Emory University History Maker during the celebration of the University's 175th Anniversary in 2011. He received a B.S. from Livingstone College, earned his PhD from Emory University and his MD degree from Duke University School of Medicine.

Schedule20 Apr 2024